William Aliski Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

William Aliski is Director of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 66,849 shares of RARE, which is worth approximately $2.9 Million. The most recent transaction as insider was on Jun 24, 2021, when has been sold 2,145 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.8K
0% 3M change
0% 12M change
Total Value Held $2.9 Million

William Aliski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2021
BUY
Grant, award, or other acquisition
-
2,145 Added 3.11%
66,849 Common Stock
Feb 23 2021
SELL
Bona fide gift
-
1,000 Reduced 1.52%
64,704 Common Stock
Feb 19 2021
SELL
Open market or private sale
$1,117,575 $149.01 p/Share
7,500 Reduced 10.25%
65,704 Common Stock
Feb 19 2021
BUY
Exercise of conversion of derivative security
$733,875 $97.85 p/Share
7,500 Added 9.29%
73,204 Common Stock

Also insider at

AGTC
APPLIED GENETIC TECHNOLOGIES CORP Healthcare
Director
XFOR
X4 Pharmaceuticals, Inc Healthcare
Director
WA

William Aliski

Director
Alachua, FL

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE